S100B is increased in Parkinson’s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway

Sathe, K, Maetzler, W, Lang, J, Mounsey, R B, Fleckenstein, C, Martin, H L, Schulte, C, Mustafa, S, Synofzik, M, Vukovic, Z, Itohara, S, Berg, D & Teismann, P 2012, 'S100B is increased in Parkinson’s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway', Brain, vol. 135, no. 11, pp. 3336-3347. https://doi.org/10.1093/brain/aws250